Wolters Kluwer N.V.: Share Buyback Transaction Details May

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
24
Wolters Kluwer N.V.: Share Buyback Transaction Details May 17 - 23, 2018

Share Buyback Transaction Details May 17 - 23, 2018

May 24, 2018 - Wolters Kluwer today reports that it has repurchased 186,146 of its own ordinary shares in the period from May 17, 2018 up to and including May 23, 2018 for €8.7 million and at an average share price of €46.51.

These share repurchases are part of the three-year share buyback program (2016-2018) originally announced on February 24, 2016. This buyback program includes repurchases made to offset annual incentive share issuance. The cumulative amounts repurchased under this three-year program are now as follows:

Share Buyback Program 2016-2018

Period Cumulative shares repurchased in period Total consideration (€ million) Average share price (€)
2018 To Date 5,061,251 217.3 42.93
2017 7,768,288 300.0 38.62
2016 5,826,473 199.7 34.28
Total 18,656,012 717.0 38.43

As stated on February 21, 2018, we intend to execute up to €400 million in share buybacks in 2018, including €200 million to mitigate the EPS dilution related to the sale of Corsearch and certain Swedish assets . In addition, following the completion of the sale of ProVation on March 9, 2018, we also intend to deploy these proceeds of this sale (€150 million) towards additional share repurchases in 2018 and 2019 to mitigate the expected EPS dilution.

Current repurchases are being executed under a third party mandate granted on May 9, 2018. Under this mandate, €100 million of share buybacks will be executed in the period from May 10, 2018, up to and including July 30, 2018.

Share repurchases are made within the limits of relevant laws and regulations, in particular Regulation (EU) 596/2014) and Wolters Kluwer's Articles of Association. Repurchased shares are added to and held as Treasury shares and will be used for capital reduction purposes or to meet obligations arising from share-based incentive plans.

Further information is available on our website:

About Wolters Kluwer Wolters Kluwer N.V. (AEX: WKL) is a global leader in information, software solutions, and services for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2017 annual revenues of €4.4 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries, and employs 19,000 people worldwide.

Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

For more information about our solutions and organization, visit www.wolterskluwer.com , follow us on Twitter , Facebook , LinkedIn , and YouTube .

Media Investors/Analysts
Annemarije Dérogée-Pikaar Meg Geldens
Corporate Communications Investor Relations
t + 31 172 641 470 t + 31 172 641 407
annemarije.pikaar@wolterskluwer.com ir@wolterskluwer.com

Forward-looking Statements and Other Important Legal Information This report contains forward-looking statements. These statements may be identified by words such as "expect", "should", "could", "shall" and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions; conditions in the markets in which Wolters Kluwer is engaged; behavior of customers, suppliers, and competitors; technological developments; the implementation and execution of new ICT systems or outsourcing; and legal, tax, and regulatory rules affecting Wolters Kluwer's businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

This press release contains information which is to be made publicly available under Regulation (EU) 596/2014.

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Navigating Cash Investments in a Shifting Yield Environment

Updated Category News Views 86

Understanding Recent Trends in the Yield Curve Recent conversations among analysts reveal a careful balance in cash and investment strategies, especially regarding potential interest rate cuts. While some believe these cuts could lead to a shift away from cash-like instruments, the situation is more nuanced. Certain segments of shorter-dated government bonds may take a...

Continue Reading
Air Canada Resumes Flights After Government Arbitration Ruling

Updated Category News Views 229

Air Canada Resumes Operations After Government Decision Air Canada has announced plans to resume flights after receiving a directive from the Canadian Industrial Relations Board (CIRB). This decision follows a government referral of existing contract negotiations between the airline and the Canadian Union of Public Employees (CUPE) to binding arbitration. Details of the...

Continue Reading
Prenosis Secures $20M Funding to Elevate Patient Outcomes

Updated Category News Views 206

Prenosis Secures $20 Million Funding for Diagnostic Innovations In a significant stride towards advancing patient care, Prenosis, a leading biology-based technology firm, announced its successful completion of a $20 million Series A financing round alongside securing a $20 million contract from the Biomedical Advanced Research and Development Authority (BARDA). This dual...

Continue Reading
Cherokee Federal Strengthens Security Services with Key Hire

Updated Category News Views 156

Cherokee Federal Expands Its Team for Enhanced Security Solutions Cherokee Federal, part of Cherokee Nation Businesses, is making significant strides in the federal contracting arena, particularly within the homeland security sector. The growing demand for effective security solutions prompted the company to enhance its capabilities. Recently, Cherokee Federal announced...

Continue Reading
China's Economic Strategies Foster Stability and Growth

Updated Category News Views 178

China's Economic Strategies Foster Stability and Growth In a recent report, Chinese officials have conveyed their strong confidence in the country's financial market, emphasizing the need for sustained and stable development. This determination reflects the country's proactive measures to adapt to an ever-evolving economic landscape. Government Initiatives to Boost Market...

Continue Reading